Stephan Sanders
Stephan Sanders is Professor of Paediatric Neurogenetics in the Department of Paediatrics at the University of Oxford, a member of faculty at the University of California, San Francisco (UCSF), and an affiliate of the New York Genome Center (NYGC). He trained as a paediatrician before undertaking a PhD and Postdoctoral studies in Genetics and Bioinformatics at Yale University. In 2014, he started his lab at the University of California, San Francisco (UCSF) before moving to Oxford in 2022. His group specialises in the genetics of autism spectrum disorder and other neurodevelopmental disorders, including genomics, functional genomics, and therapeutics. Dr. Sanders is the Director of the MRC Centre of Research Excellence in Therapeutic Genomics, co-leads the Genetics Medicine Frontier Hub of the Aligning Research to Impact Autism (ARIA) project and is a leader of the Autism Sequencing Consortium and a SFARI Sex Differences Collaboration project.
Laurent Servais
Laurent Servais is Professor of Paediatric Neuromuscular Diseases at the University of Oxford in the UK, and invited Professor at the University of Liège in Belgium. He graduated in medicine and pediatrics from the University of Louvain (in Louvain-la-Neuve and Brussels in Belgium) then trained as a child neurologist in the Robert Debré Hospital in Paris, France, and as a myologist at the Institute of Myology, Pitié-Salpêtrière University Hospital, Paris.
Professor Servais’ main research interests cover innovative outcome measures and clinical trials design and newborn screening (NBS). He has been involved as Principal Investigator in several clinical trials in spinal muscular atrophy (SMA), Angelman Syndrome X-linked myotubular myopathy, and Duchenne muscular dystrophy (DMD), and in leading the NBS program for SMA NBS in Belgium and in the UK. He is the coordinating investigator of two large natural history studies in Angelman in the UK and in Belgium that aims to identify and validates innovative outcome measures and biomarkers.
Isabel Hatami
Project Manager for the STRONG (Specialised Translational Research Oxford Neuromuscular Group), with over 8 years’ experience delivering clinical research in nutrition and neuromuscular diseases. With experience in commercial and academic settings, from nutritional intervention studies to managing studies for newborn screening and natural history of neuromuscular diseases.
Andy Yao
Andy Yao is a clinical data manager with 10 years of international experience in clinical research. He led Oxford Vaccine Group’s various COVID vaccine trials and is currently leading STRONG’s data federation project.